Literature DB >> 15197712

Diagnosis and management of pergolide-induced fibrosis.

Pinky Agarwal1, Stanley Fahn, Steven J Frucht.   

Abstract

We report on 2 patients treated with pergolide, 1 of whom developed pleural fibrosis and the other retroperitoneal fibrosis. In both cases, an extensive diagnostic evaluation and surgical intervention were required to reach a diagnosis. Based on our experience with these patients and a review of cases of pergolide-induced fibrosis in the English-language literature, we propose guidelines for the diagnosis and management of this rare complication. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197712     DOI: 10.1002/mds.20200

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole.

Authors:  Dimitrios Parissis; Athanasia Papachristodoulou; Athanasios Dimitriadis
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

Review 2.  Alternatives to levodopa in the initial treatment of early Parkinson's disease.

Authors:  Andrew Lees
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

4.  Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide.

Authors:  Evzen Růzicka; Hana Línková; Martin Penicka; Olga Ulmanová; Lucie Nováková; Jan Roth
Journal:  J Neurol       Date:  2007-08-24       Impact factor: 6.682

5.  Retroperitoneal fibrosis: a rare cause of acute renal failure.

Authors:  Amaka Ezimora; Marquetta L Faulkner; Oluwafisayo Adebiyi; Abimbola Ogungbemile; Salas-Vega Marianna; Chike Nzerue
Journal:  Case Rep Nephrol       Date:  2012-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.